Seeing Is Believing
Currently out of the existing stock ratings of Mani Foroohar, 111 are a BUY (52.61%), 85 are a HOLD (40.28%), 15 are a SELL (7.11%).
Analyst Mani Foroohar works with a stock forecast success ratio of 50.08% fulfilled within 201.16 days on average. Previously, Mani Foroohar worked at LEERINK.
Mani Foroohar’s has documented 384 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 17-Mar-2024.
Analyst best performing recommendations are on FDMT (4D MOLECULAR THERAPEUTICS ).
The best stock recommendation documented was for FDMT (4D MOLECULAR THERAPEUTICS ) at 11/14/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.51 (11.19%) receiving and performance score of 111.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
22
$12.81 (139.39%)
4
2 days ago
4/5 (80%)
$12.81 (139.39%)
279
Buy
6
$4.05 (207.69%)
4
7 months 26 days ago
4/7 (57.14%)
$4.22 (237.08%)
196
Buy
4
$-5.19 (-56.47%)
2
8 months 20 days ago
4/4 (100%)
$2.11 (111.64%)
432
Hold
3
$-6.19 (-67.36%)
6
1 years 5 months 20 days ago
3/4 (75%)
$2.23 (289.61%)
528
Hold
2
$-7.19 (-78.24%)
5
2 years 9 months 8 days ago
3/3 (100%)
$-0.36 (-15.25%)
397
Which stock is Mani Foroohar is most bullish on?
Which stock is Mani Foroohar is most reserved on?
What Year was the first public recommendation made by Mani Foroohar?